MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter Browse
Alzheimer’s disease has long been the sole province of pharmaceutical and biotech companies, but digital therapeutics companies aim to work their way into the conversation. Excerpted from our recent MedTech Strategist feature.
Every year 60+ million surgical procedures are performed in the United States—more than 100 every minute. Little wonder that digital surgery’s potential is generating excitement and investment among medical technology companies both large and small, as well as other healthcare ecosystem stakeholders. By Glenn Snyder and Matt Yanchek, Deloitte Consulting LLP.
Every year 60+ million surgical procedures are performed in the United States—more than 100 every minute. Little wonder that digital surgery’s potential is generating excitement and investment among medical technology companies both large and small, as well as other healthcare ecosystem stakeholders. By Glenn Snyder and Matt Yanchek, Deloitte Consulting LLP.
Every year 60+ million surgical procedures are performed in the United States—more than 100 every minute. Little wonder that digital surgery’s potential is generating excitement and investment among medical technology companies both large and small, as well as other healthcare ecosystem stakeholders. By Glenn Snyder and Matt Yanchek, Deloitte Consulting LLP.